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RESEARCH NOTE
spa typing directly from a mecA, spa and
pvl multiplex PCR assay—a cost-effective
improvement for methicillin-resistant
Staphylococcus aureus surveillance
A. R. Larsen, M. Stegger and M. Sørum
National Centre for Antimicrobials and Infection
Control, Statens Serum Institut, Copenhagen,
Denmark
ABSTRACT
Rapid detection and typing of methicillin-resis-
tant Staphylococcus aureus are important compo-
nents of infection control programmes. A protocol
is described that enables sequencing of the spa
gene fragment directly from a multiplex PCR
targeting the clinically relevant mecA, pvl and spa
genes, resulting in high-throughput characterisa-
tion of S. aureus. Implementation of the method in
the Danish national reference laboratory has
markedly reduced the use of reagents and the
requirement for hands-on time, and has also
provided fast typing results. In addition, the
method reduces the risk of sample mishandling.
Keywords Detection, direct sequencing, MRSA, mul-
tiplex PCR, spa typing, typing
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The emergence and spread of strains of meth-
icillin-resistant Staphylococcus aureus (MRSA) is
a major healthcare concern in many parts of the
world. MRSA surveillance should include, as a
minimum, detection of the mecA gene and
typing of the isolates, and detection of the pvl
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genes encoding Panton–Valentine leukocidin is
often of interest [1,2]. In Denmark, all MRSA
isolates are referred to the Statens Serum Insti-
tut (SSI), Copenhagen, for typing. In 2007, spa
typing replaced pulsed-field gel electrophoresis
at SSI as the primary typing method for MRSA
because of its high discriminatory power and
other advantages with respect to speed, inter-
pretation and communicability. The present
study describes a method that, in addition to
conventional spa typing, detects the presence of
the mecA and pvl genes in a single multiplex
PCR. As spa typing involves DNA sequencing,
the method also introduces the concept of
sequencing one PCR fragment directly from
among a mixture of PCR amplicons. Direct
sequencing from the multiplex PCR minimises
the number of PCRs required and the risk of
sample mishandling.
DNA templates were prepared according to
Kumari et al. [3]. Each PCR contained 0.45 lM
mecA primers (mecA P4, 5¢-TCCAGATTACA
ACTTCACCAGG; mecA P7, 5¢-CCACTTCA
TATCTTGTAACG) [4], 0.18 lM spa primers
(spa-1113f, 5¢-TAAAGACGATCCTTCGGTGAGC;
spa-1514r, 5¢-CAGCAGTAGTGCCGTTTGCTT)
[5], 1 lM pvl primers (pvl-FP, 5¢-GCTGGACAAA
ACTTCTTGGAATAT; pvl-RP, 5¢-GATAGGAC
ACCAATAAATTCTGGATTG) [6], 1 · Multiplex
PCR Master Mix (Qiagen, Valencia, CA, USA),
0.5 · Q-Solution (Qiagen) and 1 lL of DNA tem-
plate preparation. Amplification was performed
in a DNA Engine DYAD (Bio-Rad, Hercules, CA,
USA), with 15 min at 94C, followed by 30 cycles
of 30 s at 94C, 1 min at 59C and 1 min at 72C,
with a final 10 min at 72C. PCR products were
visualised on E-Gels 2% w ⁄ v (Invitrogen,
Carlsbad, CA, USA). The PCR products were
vacuum-purified using NucleoFast 96 PCR plates
(Macherey-Nagel, Easton, PA, USA) according to
the manufacturer’s instructions. Sequencing of
the amplicons with the PCR primers was per-
formed as described previously using an ABI 3130
sequencer [5]. Ridom StaphType (Ridom,Mu¨nster,
Germany) and BioNumerics v.4.6 (Applied
Maths, Sint-Martens-Latem, Belgium) software,
together with the multilocus sequence typing
database (http://www.MLST.net), were used for
analysis and annotation of the sequences gener-
ated from the isolates.
The protocol was validated against 70 known
MRSA isolates, 25 isolates of coagulase-negative
staphylococci, and the three reference strains
ATCC 6538 (methicillin-susceptible S. aureus),
ATCC 33591 (MRSA) and ATCC 51625
(methicillin-resistant Staphylococcus epidermidis).
Thirty-five of the 70 MRSA isolates had previ-
ously been confirmed as pvl-positive according to
the PCR method described by Lina et al. [7]. The
multiplex assay was initially optimised as a
duplex PCR containing the mecA and spa primers,
and was later expanded to include the pvl
primers. Both PCRs were validated with the
collection of isolates described above.
The MRSA isolates had been assigned previ-
ously to clonal complexes (CCs) by pulsed-field
gel electrophoresis, spa typing and, in some
instances, multilocus sequence typing. The iso-
lates belonged to 11 CCs (CC5, CC8, CC9, CC22,
CC30, CC45, CC59, CC72, CC78, CC80 and
CC152) and harboured SCCmec types I–VI. The
known pvl-positive isolates belonged to nine
different CCs, including the USA300-0114 (ST8-
MRSA-IV), European CA-MRSA (ST80-MRSA-IV)
and Southwest Pacific (ST30-MRSA-IV) clones
(Fig. 1). Of the coagulase-negative staphylococcus
isolates tested (11 S. epidermidis, seven Staphylo-
coccus hominis, two Staphylococcus lugdunensis, two
Staphylococcus capitis, two Staphylococcus haemolyt-
icus and one Staphylococcus warneri), 11 were
mecA-positive. The mecA status and species iden-
tifications were confirmed using the EVIGENE
MRSA detection kit (SSI, Copenhagen, Denmark),
and the RapidStaph32 system (bioMe´rieux,
Marcy-l’E´toile, France).
1 2 3 4 5 6 7 8 9 10 11 12
mecA (162 bp) 
pvl (80 bp) 
spa (variable) 
Fig. 1. Examples of isolates typed by the spa, mecA and pvl
multiplex PCR. Lanes: 1 and 12, 100-bp ladder; 2, H2O
control; 3, Staphylococcus epidermidis DK-14; 4, S. epidermidis
ATCC 51625; 5, methicillin-susceptible Staphylococcus
aureus (MSSA) ATCC 6538; 6, MSSA DK-E2211; 7, meth-
icillin-resistant Stapylococcus aureus (MRSA) ATCC 33591;
8, MRSA USA300-0114; 9, MRSA CC80 (282-01); 10, MRSA
CC30 (3250-01); 11, MRSA DK-55599 (one spa repeat).
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The results of the initial validation showed
complete concordance with the results obtained
previously according to mecA, spa and pvl PCRs
performed individually. The mecA and pvl
amplicons from the multiplex PCR were
sequenced to confirm the identity of the ampli-
cons and to test the feasibility of direct sequenc-
ing of a particular amplicon from a multiplex
PCR mixture.
Following the initial validation of the PCR
method with only the mecA and spa primers, the
duplex protocol was introduced routinely at SSI
during January 2007. Testing of 759 routine sam-
ples identified 686 MRSA and 73 methicillin-
susceptible S. aureus isolates. Sequencing revealed
102 different spa types among the MRSA isolates,
of which ten were identified as new types accord-
ing to the Ridom spa server (www.ridom.de). Of
the 102 spa types, 79 were assigned to 16 different
CCs, while 23 spa types (42 isolates) could not be
assigned to CC groups. Isolates containing only
one spa repeat (spa type t693; r07) were still
detected correctly (Fig. 1, lane 11). Nine isolates
failed to yield the spa gene fragment, but were
confirmed as S. aureus by coagulase tests and by
detection of the nuc and femA genes by PCR [8–10].
The multiplex method described in this report
provides an efficient protocol for detecting three
of the most important determinants used in
surveillance of MRSA. The method confirms the
presence of the mecA gene and detects the pvl
genes in the same PCR used for conventional spa
typing, which makes the procedure less expensive
and laborious than performing separate reactions.
Like conventional spa typing, the method is a fast,
sequence-based typing method for S. aureus. Typ-
ing results are currently available in 2 working
days, but could be made available in 1 day if
facilities allow. Since January 2007, typing results
have been reported twice-weekly from the labo-
ratory, thereby providing timely results for local
infection control purposes. Although the pvl
genes are not restricted solely to community-
acquired MRSA, pvl is present in all major
community-acquired MRSA lineages and enables,
e.g., distinction of USA300 isolates from other ST8
isolates [1,2,11].
To our knowledge, spa-sequencing directly
from the products of a multiplex PCR has not
been described previously. Other MRSA sequence
typing protocols have involved other genes
encoding surface proteins, e.g., clfB, in addition
to spa, in order to improve the discriminatory
power [12]. The concept presented here of direct
sequencing of a single cohort of PCR products
from among a mixture of different amplicons can
be transferred easily to such protocols, thus
enabling, e.g., spa and clfB to be sequenced from
the same multiplex PCR.
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ABSTRACT
Penicillinase testing is required for Staphylococcus
aureus isolates with a penicillin MIC of
£0.12 mg ⁄L. This study compared five pheno-
typic assays with a PCR for blaZ when testing 197
S. aureus isolates. The starch–iodine plate method
and nitrocefin tests had low sensitivities of 42.9%
and 35.7%, respectively. The cloverleaf assay and
the penicillin zone-edge determination method
had sensitivities of 67.8% and 71.4%, respec-
tively, and these methods might be appropriate in
many circumstances, but were not as sensitive as
blaZ PCR.
Keywords blaZ, PCR, penicillinase, phenotypic assays,
sensitivity testing, Staphylococcus aureus
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Resistance to penicillin in Staphylococcus aureus is
mediated by production of a penicillinase,
encoded by blaZ. Four types of penicillinase
(termed A–D) have been described in S. aureus,
all of which are Ambler class A b-lactamases [1].
Reliable detection of penicillinase production is
important because penicillin is considered to be
superior to oxacillin against isolates that do not
produce a penicillinase. An erroneus report of
penicillin susceptibility could result in potentially
inadequate therapy of S. aureus infections. A
penicillin MIC of £0.12 mg ⁄L is formally in the
sensitive range, but the CLSI recommends that
additional testing should be performed [2]. The
aim of the present study was to compare five
phenotypic methods for penicillinase detection,
i.e., penicillin disk-diffusion, penicillin zone-edge
determination, a cloverleaf assay, nitrocefin tests
and a starch–iodine plate method, against a PCR
assay for blaZ when testing the sub-population of
isolates with a penicillin MIC in the formally
sensitive range according to the Vitek 2 system
(bioMe´rieux, Durham, NC, USA).
Consecutive non-duplicate isolates of S. aureus
(n = 197) were collected if their penicillin MIC
according to Vitek 2 was £0.12 mg ⁄L. Disk-
diffusion tests for penicillin were performed
according to CLSI recommendations [2] (10-U
disk; Oxoid, Basingstoke, UK). The penicillin
zone-edge was checked for a sharp edge with
discrete full-sized colonies right at the edge, or for
a tapered edge with a gradual decrease in growth
[3]. A sharp edge was considered to be indicative
of penicillinase production. Zone inhibition diam-
eters were measured, with a diameter of £28 mm
for penicillin being considered to be penicillinase-
positive [2]. The cloverleaf assay was performed
as described previously [4], except that S. aureus
ATCC 25923 was used as the indicator strain on
Mueller–Hinton agar (Merck, Darmstadt, Ger-
many). Testing with nitrocefin sticks (Oxoid)
was performed according to the manufacturer’s
instructions, with colonies located at the penicillin
zone-edge, and was read after 5, 15 and 60 min.
The starch–iodine plate method was performed as
described previously [4], except that oxacillin
(Sigma, Taufkirchen, Germany) 0.2 mg ⁄L was
used for penicillinase induction instead of meth-
icillin. Decolourisation under and around the
colonies was considered to be a positive result.
Primers for amplification of blaZ, designed
according to blaZ sequences published previ-
ously, were stau-blaZ-fwd (5¢-CAAAGATGA
TATAGTTGCTTATTCTCC) and stau-blaZ-rev
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